CYCLIC PYRIMIDIN-4-CARBOXAMIDES AS CCR2 RECEPTOR ANTAGONISTS FOR TREATMENT OF INFLAMMATION, ASTHMA AND COPD
摘要
<p>The present invention relates to a process for the production of novel antagonists for CCR2 (CC chemokine receptor 2) of formula (I) from 6-Chloro-pyrimidine-methanone intermediates.
Formula (I):
Specifically claimed 6-chloropyrimidine-methanone intermediates are:</p>